BRCA2 and fallopian tube cancer: The ML analysis identified CA125 levels, patient age, and MatoRRSO as primary risk factors for ovarian and fallopian tube cancers in BRCA1 and BRCA2 mutation carriers, consistent with current clinical understanding.